Macrophage immune signaling pathways

Macrophage immune signaling pathways represent the integrated network of intracellular biochemical cascades that regulate the functional states of macrophages in response to environmental stimuli. These pathways are primarily initiated by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), and various cytokine receptors, leading to the activation of key transcription factors including NF-κB, AP-1, and STATs (Source: Nature Reviews Immunology, 2016). These signals determine whether a macrophage adopts a pro-inflammatory (M1) or an anti-inflammatory/pro-repair (M2) phenotype, which is critical for the resolution of infection or the progression of chronic diseases (Source: Frontiers in Immunology, 2020). In oncology, these pathways are often hijacked by the tumor microenvironment to suppress anti-tumor immunity and promote angiogenesis, making them a focus for checkpoint inhibition and repolarization therapies (Source: Journal of Clinical Investigation, 2017). While the term describes a broad biological system rather than a single druggable protein, many of its constituent components, such as JAK kinases and TNF receptors, are major therapeutic targets in modern medicine (Source: NIH/NCBI).

Other names

Macrophage activation pathwaysMacrophage signaling networkMonocyte-macrophage signaling cascades

Therapeutic agents modulate these pathways by inhibiting specific signaling nodes, such as pro-inflammatory cytokines (TNF, IL-1, IL-6) or intracellular kinases (JAK, MAPK), to alter macrophage activation and polarization states.